Yate-Ching Yuan

发表

BD-Func: a streamlined algorithm for predicting activation and inhibition of pathways

Charles D. Warden, Noriko Kanaya, Shiuan Chen, 2013, PeerJ.

State-Transition Analysis of Time-Sequential Gene Expression Identifies Critical Points That Predict Leukemia Development

Lei Wang, Zheng Liu, Sergio Branciamore, 2017 .

UC Office of the President Recent Work Title De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer

Weiying Zhou, Yun Yen, John J Rossi, 2012 .

Rlip depletion prevents spontaneous neoplasia in TP53 null mice

Zheng Liu, Meenakshi Awasthi, Sanjay Awasthi, 2018, Proceedings of the National Academy of Sciences.

3-O-methylthespesilactam, a new small-molecule anticancer pan-JAK inhibitor against A2058 human melanoma cells.

Qiang Xiao, Lucy Liu, Yate-Ching Yuan, 2013, Biochemical pharmacology.

Letrozole-, Anastrozole-, and Tamoxifen-Responsive Genes in MCF-7aro Cells: A Microarray Approach

David Smith, Toru Itoh, Shiuan Chen, 2005, Molecular Cancer Research.

COHCAP: an integrative genomic pipeline for single-nucleotide resolution DNA methylation analysis

Hua Yu, Charles D. Warden, Yate-Ching Yuan, 2013, Nucleic acids research.

AroER tri-screen is a biologically relevant assay for endocrine disrupting chemicals modulating the activity of aromatase and/or the estrogen receptor.

Menghang Xia, Srilatha Sakamuru, Noriko Kanaya, 2014, Toxicological sciences : an official journal of the Society of Toxicology.

Profiles of Epigenetic Histone Post-translational Modifications at Type 1 Diabetes Susceptible Genes*

Zheng Liu, Yate-Ching Yuan, Rama Natarajan, 2012, The Journal of Biological Chemistry.

Pharmacodynamic and pharmacogenomic study of the nanoparticle conjugate of camptothecin CRLX101 for the treatment of cancer.

Yun Yen, Mark E. Davis, Yate-Ching Yuan, 2014, Nanomedicine : nanotechnology, biology, and medicine.

Characterization of the interacting mechanisms between Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) and the small subunits of human Ribonucleotide Reductase

Yun Yen, Yate-Ching Yuan, Bingsen Zhou, 2005 .

A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance.

Yun Yen, David Horne, Yate-Ching Yuan, 2013, Cancer research.

Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma

Yuman Fong, Zheng Liu, Jianming Lu, 2018, Oncotarget.

Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor.

Xin Wang, Shiuan Chen, Yate-Ching Yuan, 2008, Cancer research.

Comprehensive Comparison of Gene Set Analysis Tools

Zheng Liu, Yate-Ching Yuan, Yate-Ching Yuan, 2011 .